252 related articles for article (PubMed ID: 21347454)
1. 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.
Mercer L; Bowling T; Perales J; Freeman J; Nguyen T; Bacchi C; Yarlett N; Don R; Jacobs R; Nare B
PLoS Negl Trop Dis; 2011 Feb; 5(2):e956. PubMed ID: 21347454
[TBL] [Abstract][Full Text] [Related]
2. SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.
Jacobs RT; Nare B; Wring SA; Orr MD; Chen D; Sligar JM; Jenks MX; Noe RA; Bowling TS; Mercer LT; Rewerts C; Gaukel E; Owens J; Parham R; Randolph R; Beaudet B; Bacchi CJ; Yarlett N; Plattner JJ; Freund Y; Ding C; Akama T; Zhang YK; Brun R; Kaiser M; Scandale I; Don R
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1151. PubMed ID: 21738803
[TBL] [Abstract][Full Text] [Related]
3. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
4. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
[TBL] [Abstract][Full Text] [Related]
5. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
Rottenberg ME; Masocha W; Ferella M; Petitto-Assis F; Goto H; Kristensson K; McCaffrey R; Wigzell H
J Infect Dis; 2005 Nov; 192(9):1658-65. PubMed ID: 16206083
[TBL] [Abstract][Full Text] [Related]
6. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
[TBL] [Abstract][Full Text] [Related]
7. Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma.
Hobbie SN; Kaiser M; Schmidt S; Shcherbakov D; Janusic T; Brun R; Böttger EC
PLoS Negl Trop Dis; 2011 May; 5(5):e1161. PubMed ID: 21629725
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Nare B; Wring S; Bacchi C; Beaudet B; Bowling T; Brun R; Chen D; Ding C; Freund Y; Gaukel E; Hussain A; Jarnagin K; Jenks M; Kaiser M; Mercer L; Mejia E; Noe A; Orr M; Parham R; Plattner J; Randolph R; Rattendi D; Rewerts C; Sligar J; Yarlett N; Don R; Jacobs R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4379-88. PubMed ID: 20660666
[TBL] [Abstract][Full Text] [Related]
9. The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.
Diaz-Gonzalez R; Kuhlmann FM; Galan-Rodriguez C; Madeira da Silva L; Saldivia M; Karver CE; Rodriguez A; Beverley SM; Navarro M; Pollastri MP
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1297. PubMed ID: 21886855
[TBL] [Abstract][Full Text] [Related]
10. Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.
Urbaniak MD; Mathieson T; Bantscheff M; Eberhard D; Grimaldi R; Miranda-Saavedra D; Wyatt P; Ferguson MA; Frearson J; Drewes G
ACS Chem Biol; 2012 Nov; 7(11):1858-65. PubMed ID: 22908928
[TBL] [Abstract][Full Text] [Related]
11. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against
Phan TN; Baek KH; Lee N; Byun SY; Shum D; No JH
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340370
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds.
Alkhaldi AA; de Koning HP; Bukhari SNA
Drug Des Devel Ther; 2019; 13():1179-1185. PubMed ID: 31118564
[No Abstract] [Full Text] [Related]
15. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery.
Boniface PK; Elizabeth FI
Curr Drug Targets; 2019; 20(12):1295-1314. PubMed ID: 31215385
[TBL] [Abstract][Full Text] [Related]
16. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
17. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
[TBL] [Abstract][Full Text] [Related]
19. Parasite Polyamines as Pharmaceutical Targets.
Roberts S; Ullman B
Curr Pharm Des; 2017; 23(23):3325-3341. PubMed ID: 28571553
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.
Pizarro JC; Hills T; Senisterra G; Wernimont AK; Mackenzie C; Norcross NR; Ferguson MA; Wyatt PG; Gilbert IH; Hui R
PLoS Negl Trop Dis; 2013; 7(10):e2492. PubMed ID: 24147171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
